Press Release
Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) announced the planned launch of HISCL™ VEGF Assay Kit for Research Use and HISCL™ PEDF Assay Kit for Research Use, research reagents for measuring secreted proteins in cell culture media in regenerative cellular medicine, in Japan, starting from June 20, 2024. The use of these products in R&D and cell manufacturing for regenerative cellular medicine is expected to contribute to the automation and greater efficiency of quality control testing of cellular therapeutics.
Name of parameter | VEGF1 | PEDF2 |
Product name |
HISCL™ VEGF Assay Kit for Research Use | HISCL™ PEDF Assay Kit for Research Use |
Intended use | Measuring the amount of human VEGF in culture supernatant | Measuring the amount of human PEDF in culture supernatant |
Manufacturer and seller | Sysmex Corporation | |
Target market | To be first introduced to the Japanese market and then to other markets | |
Launch | June 20, 2024 |
Katy Spink, Andrew Steinsapir: Cell Gene Therapy Insights, 4(11), 1105-1116, 2018. |
1 |
VEGF (vascular endothelial growth factor):
A group of glycoproteins involved in vascularization (the formation of new blood vessels in areas with no blood vessels during embryogenesis) and angiogenesis (the formation of blood vessels by branching and elongating from existing vessels)
|
||
2 |
PEDF (pigment epithelium derived factor):
A multifunctional secreted protein with anti-angiogenic, anti-tumorigenic, and neurotrophic functions
|
Sysmex Corporation, headquartered in Kobe, Japan, is a global leader in in vitro diagnostics. Since its foundation in 1968, Sysmex has focused on diagnostics as the core of its business, and today, it supports the health of people in over 190 countries and regions worldwide. Sysmex continues to innovate in diagnostics, and to collaboratively create unique values in the areas of personalized medicine and novel treatments, under its long-term vision of "Together for a better healthcare journey." Through its unique technology, solutions, and co-creation with various partners, Sysmex delivers new value and addresses the universal desire of people to live longer and healthier lives.
For more information about Sysmex, please visit www.sysmex.co.jp/en/.
FOLLOW US